Research indicates that genetic variations are key for understanding the genetic basis of complex traits and diseases. Variants can influence phenotypes, the susceptibility of an individual to disease, drug response and human genome evolution. Many SNPs have been associated with common disorders such as diabetes, obesity, and cardiovascular diseases. Further research into identifying the risk factors and understanding the biology of risk variants would enable a more complete view of these conditions and lead to improved disease treatment and prevention.
Studies show that APOA5 takes part in the metabolism of the triglicerides, accelerating the catalysis of the LDL and the activation of proteín lipase. Research studies have show that the presence of allele C at position 1131 is related to an increase of risk of cardiovascular disease.
Apolipoprotein A-V
| Assay ID | Clinical Name | Gene Symbol | Gene Name | dbSNP ID | |
| C___2310403_10 | APOA5 1131T>C | APOA5 | Apolipoprotein A-V | rs662799 |
| # of assays: | 1 |
| Technology: | TaqMan® Assays |
| Scale: | Available in multiple scales |
| Intended Use: | Research Use Only |
-20° C
